Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Neuropsychopharmacology - United Kingdom
doi 10.1038/sj.npp.1300260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Chronic Stress Decreases the Number of Parvalbumin-Immunoreactive Interneurons in the Hippocampus: Prevention by Treatment With a Substance P Receptor (NK1) Antagonist

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2004English

The Broad-Spectrum Anti-Emetic Activity of the Novel Non-Peptide Tachykinin NK1 Receptor Antagonist GR203040

British Journal of Pharmacology
Pharmacology
1995English

Effects of CP-96,345, a Novel Non-Peptide Antagonist of NK1 Receptor, on the Peristalsis in Isolated Guinea Pig Ileum.

The Japanese Journal of Pharmacology
1992English

Substance P-Induced Inflammatory Responses in Guinea-Pig Skin: The Effect of Specific NK1 Receptor Antagonists and the Role of Endogenous Mediators

British Journal of Pharmacology
Pharmacology
1995English

Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly

Endocrine Journal
EndocrinologyMetabolismDiabetes
2016English

The Effects of Substance P on Cultured Fibroblastic Synovial Cells Through the NK1-R

The Journal of the Kyushu Dental Society
2003English

Effect of TAK-637, a Tachykinin NK1-Receptor Antagonist, on Lower Urinary Tract Function in Cats.

The Japanese Journal of Pharmacology
2001English

Antidepressant-Like Effects of a Novel 5-Ht3 Receptor Antagonist 6z in Acute and Chronic Murine Models of Depression

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

P-Glycoprotein (ABCB1) Limits the Brain Distribution of YQA-14, a Novel Dopamine D3 Receptor Antagonist

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy